These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1107 related items for PubMed ID: 18307377

  • 21. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
    Wilens TE.
    J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
    [Abstract] [Full Text] [Related]

  • 22. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B, Sopko MA, Ehret MJ, Paulino RE, Goldberg KR, Angstadt K, Bogart GT.
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [Abstract] [Full Text] [Related]

  • 23. Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
    Kollins SH.
    Am J Addict; 2007 Jun; 16 Suppl 1():35-42; quiz 43-4. PubMed ID: 17453605
    [Abstract] [Full Text] [Related]

  • 24. The effect of stimulant treatment for ADHD on later substance abuse and the potential for medication misuse, abuse, and diversion.
    Faraone SV, Upadhyaya HP.
    J Clin Psychiatry; 2007 Nov; 68(11):e28. PubMed ID: 18052554
    [Abstract] [Full Text] [Related]

  • 25. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A.
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [Abstract] [Full Text] [Related]

  • 26. ADHD in adults: current treatment trends with consideration of abuse potential of medications.
    Mao AR, Babcock T, Brams M.
    J Psychiatr Pract; 2011 Jul; 17(4):241-50. PubMed ID: 21775825
    [Abstract] [Full Text] [Related]

  • 27. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E, Levy S, Committee on Substance Abuse.
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Innovations in attention-deficit/hyperactivity disorder pharmacotherapy: long-acting stimulant and nonstimulant treatments.
    Stein MA.
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S89-98. PubMed ID: 15352535
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Attention deficit hyperactivity disorder in prison: a treatment protocol.
    Appelbaum KL.
    J Am Acad Psychiatry Law; 2009 Jul; 37(1):45-9. PubMed ID: 19297632
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Childhood attention deficit hyperactivity disorder and the development of substance use disorders: valid concern or exaggeration?
    Looby A.
    Addict Behav; 2008 Mar; 33(3):451-63. PubMed ID: 18037571
    [Abstract] [Full Text] [Related]

  • 34. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC, Nutt DJ.
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E, Gastpar M.
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.